• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎:全科医生应该知道什么?

COVID-19: What Should the General Practitioner Know?

机构信息

Department of Rheumatology, Rehabilitation and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Clin Interv Aging. 2021 Jan 7;16:43-56. doi: 10.2147/CIA.S268607. eCollection 2021.

DOI:10.2147/CIA.S268607
PMID:33442244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7800435/
Abstract

BACKGROUND

SARS-CoV-2 infection is currently the most significant public health challenge. Its presentation ranges from mild to severe respiratory failure and septic shock. Rapid transmission of the virus is dangerous with a high possibility of life-threatening complications. Lack of treatment standards for SARS-CoV-2 is responsible for the current dilemma in clinical medicine.

METHODS

An electronic literature search was done using PubMed to gather information on the pathogenesis, transmission of infection, clinical symptoms, diagnosis, and therapeutic options for COVID-19. Search items included "SARS-CoV-2", "COVID-19" and "coronavirus infection".

RESULTS

In light of the current global crisis caused by SARS-CoV-2, the exchange of information within the scientific community should be quick and extremely transparent. Thus, this review presents the available information necessary for a general practitioner. Such presentation of data should allow the reader quick access to basic and crucial information related to epidemiology, viral transmission, clinical symptoms, diagnostics, treatment, and complications that may occur in the course of COVID-19.

CONCLUSION

Rapidly increasing amounts of information about the diagnosis and treatment of patients with SARS-CoV-2 allow a better understanding of the etiology and course of the infection. In the current epidemiological situation, readily accessible information helps minimize the time to acquire knowledge and focus on prevention methods, diagnostic and treatment options. Thus, this review highlights key issues related to SARS-CoV-2 infection and contains the most useful data for daily medical practice.

摘要

背景

目前,严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染是对公共卫生最大的挑战。其临床表现从轻症到严重呼吸衰竭和感染性休克不等。病毒的快速传播很危险,有很高的危及生命的并发症的可能性。缺乏针对 SARS-CoV-2 的治疗标准是目前临床医学面临的困境。

方法

利用 PubMed 进行电子文献检索,收集有关 COVID-19 的发病机制、感染传播、临床症状、诊断和治疗选择的信息。检索项包括“SARS-CoV-2”“COVID-19”和“冠状病毒感染”。

结果

鉴于目前由 SARS-CoV-2 引起的全球危机,科学界内部的信息交流应该迅速且极其透明。因此,这篇综述介绍了全科医生所需的现有信息。这种数据呈现方式应使读者能够快速访问与 COVID-19 相关的流行病学、病毒传播、临床症状、诊断、治疗和可能发生的并发症的基本和关键信息。

结论

关于 SARS-CoV-2 患者的诊断和治疗的信息量迅速增加,有助于更好地了解感染的病因和病程。在当前的流行病学形势下,易于获取的信息有助于缩短获取知识的时间,并专注于预防方法、诊断和治疗选择。因此,本综述突出了与 SARS-CoV-2 感染相关的关键问题,并包含了日常医疗实践中最有用的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/7800435/d5a5fa7adf91/CIA-16-43-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/7800435/d5a5fa7adf91/CIA-16-43-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/7800435/d5a5fa7adf91/CIA-16-43-g0001.jpg

相似文献

1
COVID-19: What Should the General Practitioner Know?新型冠状病毒肺炎:全科医生应该知道什么?
Clin Interv Aging. 2021 Jan 7;16:43-56. doi: 10.2147/CIA.S268607. eCollection 2021.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
4
The increasing importance of the novel Coronavirus.新型冠状病毒的重要性日益增加。
Hosp Pract (1995). 2021 Feb;49(1):1-11. doi: 10.1080/21548331.2020.1828888. Epub 2020 Oct 20.
5
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
6
Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.纽约市一家大型医疗中心感染严重急性呼吸综合征冠状病毒 2 的母亲所生新生儿的结局。
JAMA Pediatr. 2021 Feb 1;175(2):157-167. doi: 10.1001/jamapediatrics.2020.4298.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
9
The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.冠状病毒感染(SARS-CoV-2、MERS-CoV 和 SARS-CoV)对妊娠的影响及垂直母婴传播的可能性:系统评价和荟萃分析。
Eur J Med Res. 2020 Sep 4;25(1):39. doi: 10.1186/s40001-020-00439-w.
10
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.严重急性呼吸综合征冠状病毒 2 引起的肺炎相关呼吸障碍(COVID-19):诊断和拟议治疗选择。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4016-4026. doi: 10.26355/eurrev_202004_20871.

引用本文的文献

1
Experience of Primary Care Physicians in the Aube Department, France, Regarding the COVID-19 Crisis.法国奥布省基层医疗医生应对新冠疫情危机的经验
Healthcare (Basel). 2022 May 5;10(5):852. doi: 10.3390/healthcare10050852.

本文引用的文献

1
A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).一项随机、单盲、成组序贯、活性对照研究,旨在评估α-硫辛酸对2019冠状病毒病(COVID-19)危重症患者的临床疗效和安全性。
Front Med (Lausanne). 2022 Feb 4;8:566609. doi: 10.3389/fmed.2021.566609. eCollection 2021.
2
Caution about early intubation and mechanical ventilation in COVID-19.关于新型冠状病毒肺炎早期插管和机械通气的注意事项。
Ann Intensive Care. 2020 Jun 9;10(1):78. doi: 10.1186/s13613-020-00692-6.
3
Increased Risk of COVID-19-Related Deaths among General Practitioners in Italy.
意大利全科医生中与新冠病毒相关死亡的风险增加。
Healthcare (Basel). 2020 Jun 3;8(2):155. doi: 10.3390/healthcare8020155.
4
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
5
Physician deaths from corona virus (COVID-19) disease.因冠状病毒(COVID-19)疾病导致的医生死亡。
Occup Med (Lond). 2020 Jul 17;70(5):370-374. doi: 10.1093/occmed/kqaa088.
6
An Update on Current Therapeutic Drugs Treating COVID-19.治疗新型冠状病毒肺炎的当前治疗药物最新情况
Curr Pharmacol Rep. 2020;6(3):56-70. doi: 10.1007/s40495-020-00216-7. Epub 2020 May 11.
7
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
8
Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study.中国湖北省非武汉地区 2019 冠状病毒病患者的临床特征:一项回顾性研究。
BMC Infect Dis. 2020 Apr 29;20(1):311. doi: 10.1186/s12879-020-05010-w.
9
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.严重急性呼吸综合征冠状病毒 2 引起的肺炎相关呼吸障碍(COVID-19):诊断和拟议治疗选择。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4016-4026. doi: 10.26355/eurrev_202004_20871.
10
Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings.新型冠状病毒肺炎患者的呼吸支持:关注资源有限的环境。
Am J Trop Med Hyg. 2020 Jun;102(6):1191-1197. doi: 10.4269/ajtmh.20-0283.